Result of AGM

RNS Number : 0274D

Avacta Group PLC

23 January 2015

 



23 January 2015

Avacta Group plc

("Avacta", the "Group" or the "Company")

Result of Annual General Meeting

Avacta Group plc (AIM: AVCT), the global provider of proprietary diagnostic tools, consumables and reagents for human and animal healthcare, announces that at the Annual General Meeting held earlier today, all resolutions were duly passed.

Following the Annual General Meeting, Gwyn Humphreys stood down from the Board with immediate effect.  The Board would like to thank Gwyn for the service and support he has given to the Company and acknowledges the contribution he has made to the Group's progress.

Avacta Group plc	www.avacta.com
Alastair Smith, Chief Executive Officer	Tel:  [phone]
Tim Sykes, Chief Financial Officer
Numis Securities Limited	Tel:  [phone]
Michael Meade / Freddie Barnfield (Nominated Adviser)
James Black  (Corporate Broking)
Walbrook PR Limited	Tel: [phone] or [e-mail]
Mike Wort	Mob: [phone]
Anna Dunphy	Mob: [phone]

About Avacta

Avacta Group plc is a global provider of research reagents, consumables and equipment to the life sciences and animal care. Avacta operates through three divisions:

Avacta Life Sciences www.avactalifesciences.com	Novel non-antibody affinity reagents called Affimers, with a wide range of Life Science applications in diagnostics, drug and biomarker discover and biotech research and development.
Avacta Animal Health www.avactaanimalhealth.com	Veterinary diagnostics reference laboratory services, SensiTest, and diagnostic kits, SensiPak.
Avacta Analytical www.avactaanalytical.com	High throughput analysis instrument, Optim, to help reduce the cost and risk of drug development.

Avacta joined AIM in August 2006 and is based in Wetherby, England.

 

END

 

 

RAGEALFDAASSEFF